| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.2B | $23.2B | $22.7B | $16.7B | $6.3B | $1.9B | $2.9B | $2.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.1B | $4.1B | $3.6B | $3.0B | $1.8B | $1.5B | $2.1B | $2.0B |
| Operating Income | $1.3B | $0.8B | $1.1B | $0.7B | $-0.4B | $-1.7B | $-0.1B | $-0.1B |
| Net Income | $0.5B | $0.9B | $0.6B | $0.3B | $-0.7B | $-1.7B | $-0.2B | $-0.1B |
| EPS (Basic) | $-0.24 | $2.77 | $1.38 | $0.66 | — | — | $-0.88 | $-0.82 |
| EPS (Diluted) | $-0.24 | $2.74 | $1.37 | $0.64 | — | — | $-0.88 | $-0.82 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.9B | $19.6B | $19.1B | $16.5B | $14.4B | $10.6B | $11.0B | $8.5B |
| Current Assets | $11.0B | $9.3B | $9.6B | $8.2B | $6.7B | $3.6B | $4.2B | $3.8B |
| Cash & Equivalents | $7.1B | $6.1B | $6.2B | $5.6B | $4.9B | $2.5B | $2.5B | $2.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $11.0B | $9.4B | $10.0B | $8.3B | $6.9B | $3.8B | $4.1B | $3.7B |
| Stockholders' Equity | $0.3B | $0.2B | $-0.0B | $-0.4B | $-0.6B | $-0.5B | $1.1B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.7B | $1.4B | $1.8B | $1.8B | $-1.1B | $0.5B | $0.9B |
| Investing Cash Flow | $-1.2B | $-0.9B | $-0.7B | $-0.8B | $-0.6B | $-0.2B | $-0.7B | $-0.5B |
| Capital Expenditures | $1.1B | $0.6B | $0.4B | $0.3B | $0.2B | $0.2B | $0.3B | $0.2B |
| Financing Cash Flow | $0.4B | $-0.7B | $-0.1B | $-0.1B | $1.2B | $1.4B | $0.3B | $0.2B |